Quantification of AML1-MTG8 fusion transcripts was performed by using real-
time reverse transcription-polymerase chain reaction (RT-PCR) and the clini
cal value of this method was evaluated in t(8;21)-positive acute myelogenou
s leukemia (AML). A t(8;21)-positive cell line, Kasumi-1, was used for cons
tructing standard curves and the corrected AML1-MTG8 mRNA expression level
relative to the expression of the GAPDH housekeeping gene was calculated. B
one marrow samples from 14 patients with t(8;21)-positive AML were sequenti
ally examined. The corrected AML1-MTG8 expression level at diagnosis varied
in the range from 0.4 to 2.7 (median, 1.5) among the patients. When sample
s at 1, 3 and 6 months were examined after diagnosis, the corrected AML1-MT
G8 expression level was found to decrease sequentially in all but one. AML1
-MTG8 fusion transcripts were also detected in four of eight samples from p
atients in remission for more than 1 year. In conclusion, real-time RT-PCR
can provide a rapid and accurate quantification of AML1-MTG8 fusion transcr
ipts. This system could be useful to reveal the prognostic relevance of min
imal residual disease in t(8;21)-positive AML. (C) 2000 Elsevier Science Lt
d. All rights reserved.